source:[1] Novo Nordisk A/S (NVO) Stock Today: Akero Deal, GLP‑1 Competition and Analyst Downgrades – What 10 December 2025 Means for Investors - ts2.tech (https://ts2.tech/en/novo-nordisk-a-s-nvo-stoc ...)[2] ROSEN, A TOP-RANKED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM - marketscreener.com (https://www.marketscreener.com/news/rosen-a-t ...)[3] Regeneron Climbs Back After a Year of Regulatory, Manufacturing Misery - BioSpace (https://www.biospace.com/business/regeneron-c ...)